Loading
A phase 1 trial of DFP-14927 run by Delta-Fly Pharma, Inc., now recruiting.
Trial of DFP-14927 in Advanced Solid Tumors is a phase 1 interventional study registered as NCT03943004 by Delta-Fly Pharma, Inc., with 30 participants planned, started 2019-09-30. Conditions recorded: Solid Tumor and Cancer. Interventions recorded: DFP-14927.
Shares Delta-Fly Pharma and the tag pipeline.
Shares Delta-Fly Pharma, Metastatic cancer (cancer that has spread) and the tag pipeline.
Shares Delta-Fly Pharma, Metastatic cancer (cancer that has spread) and the tag pipeline.
Shares Delta-Fly Pharma and the tag pipeline.
Shares Delta-Fly Pharma and the tag pipeline.
Shares Delta-Fly Pharma and the tag pipeline.
Shares Metastatic cancer (cancer that has spread) and the tag pipeline.
Shares Metastatic cancer (cancer that has spread) and the tag pipeline.
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
A source that has moved or gone is reported by the weekly link check. /audit/